Furthermore, overexpression of KLK7 mRNA and protein product have been related to poor clinical prognosis of CRC patients [30, 31], and the use of alternative promoters has been indicated in tissue or disease-specific KLK regulation [32]. This evidence concerns the gene KLK7 and colorectal carcinoma.